| Dr Suraj S Venna, MD | |
|
8081 Innovation Park Dr, Fairfax, VA 22031-4867 | |
| (571) 472-4724 | |
| (571) 472-0241 |
| Full Name | Dr Suraj S Venna |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 23 Years |
| Location | 8081 Innovation Park Dr, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366433302 | NPI | - | NPPES |
| 2100550 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 218355 (Massachusetts) | Secondary |
| 207N00000X | Dermatology | 0101255078 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).
Patients with glioblastoma, an aggressive brain tumor who received a type of electric fields therapy that interferes with cell division had better overall survival and survival without progression of the tumor compared to standard chemotherapy.
As waistlines and healthcare costs continue to expand, organizations face an ongoing challenge - how to change unhealthy employee habits that affect sick time, productivity, and medical expenses. One of the most effective ways to engage employees in workplace wellness programs is having them work with colleagues, family, and friends to reach their goals.
Dana-Farber Cancer Institute today announced it has reached its $1 billion Mission Possible: The Dana-Farber Campaign to Conquer Cancer fundraising goal one year early. The first hospital in New England to set and reach a $1 billion campaign goal, Dana-Farber will continue to raise funds for campaign priorities until Sept. 30, 2010, when the campaign was scheduled to end.
"In one of the most significant victories for public health policy, the Australian High Court upheld the Tobacco Plain Packaging Act, which effectively removes the last form of advertising available to the tobacco industry in the country - logos on cigarette packs," Cynthia Lewis, a senior program officer for the tobacco initiative at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.
› Verified 3 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).
Patients with glioblastoma, an aggressive brain tumor who received a type of electric fields therapy that interferes with cell division had better overall survival and survival without progression of the tumor compared to standard chemotherapy.
As waistlines and healthcare costs continue to expand, organizations face an ongoing challenge - how to change unhealthy employee habits that affect sick time, productivity, and medical expenses. One of the most effective ways to engage employees in workplace wellness programs is having them work with colleagues, family, and friends to reach their goals.
Dana-Farber Cancer Institute today announced it has reached its $1 billion Mission Possible: The Dana-Farber Campaign to Conquer Cancer fundraising goal one year early. The first hospital in New England to set and reach a $1 billion campaign goal, Dana-Farber will continue to raise funds for campaign priorities until Sept. 30, 2010, when the campaign was scheduled to end.
"In one of the most significant victories for public health policy, the Australian High Court upheld the Tobacco Plain Packaging Act, which effectively removes the last form of advertising available to the tobacco industry in the country - logos on cigarette packs," Cynthia Lewis, a senior program officer for the tobacco initiative at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.
› Verified 3 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1275097123 PECOS PAC ID: 2466351093 Enrollment ID: O20190509001539 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).
Patients with glioblastoma, an aggressive brain tumor who received a type of electric fields therapy that interferes with cell division had better overall survival and survival without progression of the tumor compared to standard chemotherapy.
As waistlines and healthcare costs continue to expand, organizations face an ongoing challenge - how to change unhealthy employee habits that affect sick time, productivity, and medical expenses. One of the most effective ways to engage employees in workplace wellness programs is having them work with colleagues, family, and friends to reach their goals.
Dana-Farber Cancer Institute today announced it has reached its $1 billion Mission Possible: The Dana-Farber Campaign to Conquer Cancer fundraising goal one year early. The first hospital in New England to set and reach a $1 billion campaign goal, Dana-Farber will continue to raise funds for campaign priorities until Sept. 30, 2010, when the campaign was scheduled to end.
"In one of the most significant victories for public health policy, the Australian High Court upheld the Tobacco Plain Packaging Act, which effectively removes the last form of advertising available to the tobacco industry in the country - logos on cigarette packs," Cynthia Lewis, a senior program officer for the tobacco initiative at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Suraj S Venna, MD 8081 Innovation Park Dr, Fairfax, VA 22031-4867 Ph: (571) 472-4724 | Dr Suraj S Venna, MD 8081 Innovation Park Dr, Fairfax, VA 22031-4867 Ph: (571) 472-4724 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).
Patients with glioblastoma, an aggressive brain tumor who received a type of electric fields therapy that interferes with cell division had better overall survival and survival without progression of the tumor compared to standard chemotherapy.
As waistlines and healthcare costs continue to expand, organizations face an ongoing challenge - how to change unhealthy employee habits that affect sick time, productivity, and medical expenses. One of the most effective ways to engage employees in workplace wellness programs is having them work with colleagues, family, and friends to reach their goals.
Dana-Farber Cancer Institute today announced it has reached its $1 billion Mission Possible: The Dana-Farber Campaign to Conquer Cancer fundraising goal one year early. The first hospital in New England to set and reach a $1 billion campaign goal, Dana-Farber will continue to raise funds for campaign priorities until Sept. 30, 2010, when the campaign was scheduled to end.
"In one of the most significant victories for public health policy, the Australian High Court upheld the Tobacco Plain Packaging Act, which effectively removes the last form of advertising available to the tobacco industry in the country - logos on cigarette packs," Cynthia Lewis, a senior program officer for the tobacco initiative at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.
› Verified 3 days ago
Benjamin Behnoud Nia, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3700 Joseph Siewick Dr Ste 302, Fairfax, VA 22033 Phone: 703-648-2488 Fax: 703-648-2489 | |
Dr. Caleb Lee, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10100 Fairfax Blvd, Fairfax, VA 22030 Phone: 703-679-1876 | |
Dr. Monica Nabil Saleh Valentin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11351 Random Hills Rd, Fairfax, VA 22030 Phone: 443-351-3376 | |
Dr. Kathleen Ellison, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8316 Arlington Blvd Ste 400, Fairfax, VA 22031 Phone: 703-641-0083 Fax: 703-641-0085 | |
Jack Michael Costa, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3650 Joseph Siewick Dr, Suite 202, Fairfax, VA 22033 Phone: 703-391-2516 Fax: 703-476-8244 | |
Dr. Amanda Derwae, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 10680 Main St Ste 200, Fairfax, VA 22030 Phone: 703-352-2620 Fax: 703-352-2620 | |
Dr. Rolla Jaber, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3700 Joseph Siewick Dr, Suite 403, Fairfax, VA 22033 Phone: 703-648-2488 Fax: 703-648-2489 |